网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
江苏省35~75岁自报高血压患者静息心率与血压控制率的关系研究
作者:管芳1  苏健2  万亚男2  陈路路2  崔岚2  覃玉2 
单位:1. 江苏省疾病预防控制中心 杂志编辑部, 江苏 南京 210009;
2. 江苏省疾病预防控制中心 慢性非传染病防制所, 江苏 南京 210009
关键词:静息心率 高血压 心率管理 血压控制 控制率 
分类号:R544.1
出版年·卷·期(页码):2026·45·第四期(591-597)
摘要:

目的: 分析自报高血压患者的静息心率水平与血压控制率之间的关系,为制定针对性防控策略提供依据。方法: 基于2021—2024年江苏省心脑血管疾病综合防控项目,采用分层整群抽样方法在江苏省12个设区市的22个区县选取35~75岁常住居民进行问卷调查和体格检查,以自报已被诊断为高血压的居民为研究对象,分析静息心率水平和血压控制率,并采用多因素Logistic回归分析静息心率与血压控制的关联。结果: 共纳入48 479例自报高血压患者,其中<60次·min-1者2 890例(占5.96%),60~79次·min-1者30 399例(占62.71%),80~84次·min-1者6 329例(占13.06%),≥85次·min-1者8 861例(占18.28%)。静息心率≥80次·min-1者15 190例,占31.33%。13 111例高血压患者血压得到控制,血压控制率为27.04%,年龄标化控制率为23.94%。多因素Logistic回归分析显示,与静息心率60~79次·min-1者相比,静息心率80~84次·min-1(OR=0.888,95%CI 0.834~0.944)和≥85次·min-1(OR=0.670,95%CI 0.633~0.710)者的血压控制率均更低(均P<0.001),且静息心率每升高10次·min-1,血压控制率下降12.5%(OR=0.875,95%CI 0.859~0.892)。剔除未服用降压药物的高血压患者进行敏感性分析,结果稳定。结论: 静息心率升高是血压控制的危险因素,高血压管理中应关注患者的静息心率,对静息心率偏快者采取综合干预措施。

Objective: To analyze the relationship between resting heart rate(RHR) and blood pressure(BP) control rate among self-reported hypertensive patients, so as to provide evidence for developing targeted hypertension prevention and control strategies. Methods: Based on data from the Comprehensive Cardiovascular and Cerebrovascular Disease Prevention and Control Project in Jiangsu Province(2021—2024), a stratified cluster sampling method was used to select permanent residents aged 35-75 years from 22 districts and counties across 12 prefecture-level cities in Jiangsu Province for questionnaires and physical examinations. Residents who self-reported a confirmed diagnosis of hypertension were enrolled as the study population. RHR levels and BP control rates were analyzed, and multivariate Logistic regression analysis was performed to examine the association between RHR and BP control. Results: A total of 48 479 patients with self-reported hypertension were enrolled. Among them, 2 890(5.96%) had a RHR<60 beats·min-1, 30 399(62.71%) had a rate between 60 and 79 beats·min-1, 6 329(13.06%) had a rate between 80 and 84 beats·min-1, and 8 861(18.28%) had a rate ≥85 beats·min-1. Overall, 15 190 individuals(31.33%) had an RHR ≥80 beats·min-1. BP was controlled in 13 111 patients, yielding an overall control rate of 27.04% and an age-standardized control rate of 23.94%. Multivariate Logistic regression analysis showed that, compared with those having an RHR of 60-79 beats·min-1, participants with an RHR of 80-84 beats·min-1(OR=0.888, 95%CI 0.834-0.944) or ≥85 beats·min-1(OR=0.670, 95%CI 0.633-0.710) had significantly lower BP control rates(both P<0.001). For every 10 beats·min-1 increase in RHR, the BP control rate decreased by 12.5%(OR=0.875, 95%CI 0.859-0.892). Sensitivity analyses excluding participants not taking anti-hypertensive medications showed consistent findings. Conclusion: Elevated RHR is a risk factor for poor BP control. RHR should be monitored in hypertension management, and comprehensive interventions should be implement for patients with a high RHR.

参考文献:

[1] WANG A,LIU X,GUO X,et al.Resting heart rate and risk of hypertension:results of the Kailuan cohort study[J].J Hypertens,2014,32(8):1600-1605;discussion1605.
[2] 李丽,黄桥梁,柳旭艳,等.中老年人群高血压的影响因素分析[J].现代医学,2024,52(3):342-349.
[3] ZHANG X,ZHANG M,LI C,et al.Associations between hypertension status and increased heart rate-China,2015[J].China CDC Wkly,2020,2(40):771-774.
[4] 孙宁玲,霍勇,黄峻.中国高血压患者心率现状调查[J].中华高血压杂志,2015,23(10):934-939.
[5] 高血压心率管理多学科共识组.中国高血压患者心率管理多学科专家共识(2021年版)[J].中国全科医学,2021,24(20):2501-2507.
[6] ZHAO M X,ZHAO Q,ZHENG M,et al.Effect of resting heart rate on the risk of all-cause death in Chinese patients with hypertension:analysis of the Kailuan follow-up study[J].BMJ Open,2020,10(3):e032699.
[7] VAN DE VEGTE Y J,EPPINGA R N,VAN DER ENDE M Y,et al.Genetic insights into resting heart rate and its role in cardiovascular disease[J].Nat Commun,2023,14(1):4646.
[8] GRASSI G,QUARTI-TREVANO F,SERAVALLE G,et al.Association between the European society of cardiology/European society of hypertension heart rate thresholds for cardiovascular risk and neuroadrenergic markers[J].Hypertension,2020,76(2):577-582.
[9] SERAVALLE G,QUARTI TREVANO F,GRASSI G.Heart rate as a predictor of cardiovascular risk[J].Minerva Med,2021,112(1):130-143.
[10] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志,2024,32(7):603-700.
[11] 中国疾病预防控制中心慢性非传染性疾病预防.中国慢性病及危险因素监测数据分析手册[M].北京:人民卫生出版社,2022.
[12] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(下)[J].中国实用内科杂志,2021,41(9):757-784.
[13] 中国血脂管理指南修订联合专家委员会,王增武,李建军,等.中国血脂管理指南(基层版2024年)[J].中国循环杂志,2024,39(4):313-321.
[14] 中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,等.中国居民肥胖防治专家共识[J].中国预防医学杂志,2022,23(5):321-339.
[15] PALATINI P,DORIGATTI F,ZAETTA V,et al.Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension:the HARVEST Study[J].J Hypertens,2006,24(9):1873-1880.
[16] PALATINI P,ROSEI E A,CASIGLIA E,et al.Management of the hypertensive patient with elevated heart rate:Statement of the Second Consensus Conference endorsed by the European Society of Hypertension[J].J Hypertens,2016,34(5):813-821.
[17] 毕海涛,苏健,陈路路,等.江苏省35~75岁居民高血压患病、血压控制情况及相关因素分析[J].中华流行病学杂志,2024,45(7):947-954.
[18] 苏健,崔岚,杜文聪,等.江苏省居民高血压患病率、知晓率、治疗率和控制率分析[J].中华流行病学杂志,2019,40(9):1139-1144.
[19] 宋子伟,张梅,张笑,等.2015年我国35岁及以上高血压患者社区健康管理与高血压治疗控制情况分析[J].中华流行病学杂志,2021,42(11):2001-2009.
[20] KOLLOCH R,LEGLER U F,CHAMPION A,et al.Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease:findings from the INternational VErapamil-SR/trandolapril STudy(INVEST)[J].Eur Heart J,2008,29(10):1327-1334.
[21] XIA Y,FAN F,HUO Y,et al.Effect of baseline resting heart rate on the risk of all-cause death in Chinese patients with hypertension[J].J Clin Hypertens,2022,24(11):1473-1481.
[22] GRASSI G,DELLORO R,QUARTI-TREVANO F,et al.Sympathetic neural mechanisms in hypertension:recent insights[J].Curr Hypertens Rep,2023,25(10):263-270.
[23] 刘景超,周支军,金建荣.静息心率与2型糖尿病发病风险的关联分析[J].现代医学,2022,50(7):870-874.
[24] SERAVALLE G,GRASSI G.Sympathetic nervous system and hypertension:new evidences[J].Auton Neurosci,2022,238:102954.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 1267285 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541